First Header Logo Second Header Logo

Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma.

Phuphanich S, Carson KA, Grossman SA, Lesser G, Olson J, Mikkelsen T, Desideri S, Fisher JD. Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma. Neuro Oncol. 2008 Aug; 10(4):617-23.

View in: PubMed